Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam

Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam

Stan D Atkin,1 Shadaan Abid,1 Michael Foster,1 Moumita Bose,1 Ashley Keller,1 Rita Hollaway,2 Helio S Sader,3 David E Greenberg,1,4 James D Finklea,1 Mariana Castanheira,3 Raksha Jain1,4 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; 2Department o...

Full description

Bibliographic Details
Main Authors: Atkin SD, Abid S, Foster M, Bose M, Keller A, Hollaway R, Sader HS, Greenberg DE, Finklea JD, Castanheira M, Jain R
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Infection and Drug Resistance
Subjects:
Ceftazidime
Avibactam
Cystic Fibrosis
Pseudomonas aeruginosa
multi-drug resistant
Online Access:https://www.dovepress.com/multidrug-resistant-pseudomonas-aeruginosa-from-sputum-of-patients-wit-peer-reviewed-article-IDR

Similar Items

Similar Items